Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of D-serine derivatives for the treatment of anxiety disorders

Use of D-serine derivatives for the treatment of anxiety disorders

US Patent 8450336 · Granted May 28, 2013

Estimated economic value: $17,292,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein int2022
Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein intera2022
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2022
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2022
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2022
Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses2022